Cited by

• Structured treatment interruptions (STI) in chronic unsuppressed HIV infection in adults.

  Pai NP, Lawrence J, Reingold AL, Tulsky JP. Pai NP, et al. Cochrane Database Syst Rev. 2006 Jul 19;2006(3):CD006148. doi: 10.1002/14651858.CD006148. Cochrane Database Syst Rev. 2006. PMID: 16856117 Free PMC article.
• Forgiveness of INSTI-Containing Regimens at Drug Concentrations Simulating Variable Adherence In Vitro.

  Acosta RK, D'Antoni ML, Mulato A, Yant SR, Cihlar T, White KL. Acosta RK, et al. Antimicrob Agents Chemother. 2022 May 17;66(5):e0203821. doi: 10.1128/aac.02038-21. Epub 2022 Apr 7. Antimicrob Agents Chemother. 2022. PMID: 35389236 Free PMC article.
• Piecewise HIV virus dynamic model with CD4(+) T cell count-guided therapy: I.

  Tang S, Xiao Y, Wang N, Wu H. Tang S, et al. J Theor Biol. 2012 Sep 7;308:123-34. doi: 10.1016/j.jtbi.2012.05.022. Epub 2012 May 31. J Theor Biol. 2012. PMID: 22659043 Free PMC article.
• Structured treatment interruptions with tenofovir monotherapy for simian immunodeficiency virus-infected newborn macaques.

  Van Rompay KK, Singh RP, Heneine W, Johnson JA, Montefiori DC, Bischofberger N, Marthas ML. Van Rompay KK, et al. J Virol. 2006 Jul;80(13):6399-410. doi: 10.1128/JVI.02308-05. J Virol. 2006. PMID: 16775328 Free PMC article.
• Immunological responses and long-term treatment interruption after human immunodeficiency virus type 1 (HIV-1) lipopeptide immunization of HIV-1-infected patients: the LIPTHERA study.

  Pialoux G, Quercia RP, Gahery H, Daniel N, Slama L, Girard PM, Bonnard P, Rozenbaum W, Schneider V, Salmon D, Guillet JG. Pialoux G, et al. Clin Vaccine Immunol. 2008 Mar;15(3):562-8. doi: 10.1128/CVI.00165-07. Epub 2008 Jan 9. Clin Vaccine Immunol. 2008. PMID: 18184824 Free PMC article. Clinical Trial.